1999
DOI: 10.1097/00019501-199910000-00002
|View full text |Cite
|
Sign up to set email alerts
|

Plasma homocysteine level and development of coronary artery disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
12
0

Year Published

2003
2003
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 0 publications
0
12
0
Order By: Relevance
“…Methylenetetrahydrofolate reductase (MTHFR) catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, and plays a critical role in homocysteine to methionine methylation [1,2]. Reduced MTHFR levels or activity leads to hyperhomocysteinemia [1], seen in patients with vascular diseases [3], and is regarded as a risk factor for coronary artery disease (CAD) and deep-vein thrombosis (DVT) [3][4][5]. The C677T mutation is a point mutation in the MTHFR gene which substitutes alanine for valine and which is associated with a decreased enzyme activity due to thermolability [6], resulting in a relative deficiency in the homocysteine-to-methionine methylation and hence pathogenesis of atherosclerotic events [6].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Methylenetetrahydrofolate reductase (MTHFR) catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, and plays a critical role in homocysteine to methionine methylation [1,2]. Reduced MTHFR levels or activity leads to hyperhomocysteinemia [1], seen in patients with vascular diseases [3], and is regarded as a risk factor for coronary artery disease (CAD) and deep-vein thrombosis (DVT) [3][4][5]. The C677T mutation is a point mutation in the MTHFR gene which substitutes alanine for valine and which is associated with a decreased enzyme activity due to thermolability [6], resulting in a relative deficiency in the homocysteine-to-methionine methylation and hence pathogenesis of atherosclerotic events [6].…”
Section: Introductionmentioning
confidence: 99%
“…For example, a high prevalence of the TT genotype was reported for Mexico (34.8%) [7], Italy (21.4%) [2], and France (16.8%), while lower prevalences were reported for Thailand (1.4%) and India (2.0%). Insofar as the MTHFR C677T mutation is among the most common inherited contributor to diseases including cardiovascular disorders [4,5], type 2 diabetes, recurrent abortions, among others, coupled with its selective distribution, the aim of this study was to determine prevalence of MTHFR C677T mutation among healthy Lebanese subjects.…”
Section: Introductionmentioning
confidence: 99%
“…Increased plasma total homocysteine is an established independent risk factor for the development of atherosclerotic vascular disease. Epidemiological studies have shown that even mild hyperhomocysteinaemia (HHcy) is associated with coronary artery disease (Kawashiri et al 1999;Abdelmouttaleb et al 2000), myocardial infarction (Al-Obaidi et al 2000;Christensen et al 2000;Senaratne et al 2000), peripheral arterial disease (Taylor et al 1999;Mansoor et al 2000), cerebrovascular disease (Zhang et al 1998;Moller et al 2000), stroke (Van Beynum et al 1999;Hankey & Eikelboom, 2001), cardiac allograft vasculopathy (Cooke et al 2000;Parisi et al 2000) and death from coronary artery disease. Plasma homocysteine (Hcy) concentration is a function of the complex interactions between genetic and environmental factors, such as vitamin status, hormonal factors, lifestyle and diet (Nygard et al 1998).…”
mentioning
confidence: 99%
“…7 In our cross sectional study, we found mean serum homocysteine level was significantly higher in younger age group (15.1±8.2 mmol/L vs. 11.2±7.8 mmol/L, p=0.009). Kawashiri et al 14 reported that plasma homocysteine level of subjects in younger IHD group was significantly higher than that of subjects in older IHD group (15.0 vs11.3 nmol/ml, p=0.03). Sadeghian et al 15 concluded that hyperhomocysteinemia is an independent risk factor for CAD in young, especially in men.…”
Section: Discussionmentioning
confidence: 95%